Proud to Fly the Meningitis Flag!

World Meningitis Day, Oct 5.

Our Latest Stories

Your Health

October 10, 2024

Cancer & Work: Acting Together

/assets/dotcom/content-app/events/banner-investors-events_20230703194346.jpg

Third quarter 2024 results

Third quarter 2024 results will be reviewed by management during a live audio webcast with the financial community. The presentation will be followed by a Q&A session. 

Friday October 25, 2024
14:00 - 15:30 CET (8:00am – 9:30am EST)

United by Purpose

Each of us plays a unique role in bringing our purpose to life.

Igniting the Potential in Everyone

We’re proud to be premium partner of Paris 2024.

Science and sport aren’t that different. Just like athletes do, we overcome setbacks to keep moving forward, not just for ourselves, but for our patients, colleagues, families and friends.

About Us

Who We Are

We are an innovative global healthcare company.

Our Pipeline

5

Therapeutic areas

78

Compounds in clinical development

29

Clinical trials in phase 3

Pursue Progress. Discover Extraordinary. 

Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better.

Our Latest Press Releases

October 11, 2024
Press Release: Sanofi in discussions to sell a controlling stake in Opella
October 9, 2024
Press Release: New Beyfortus data featured at IDWeek reinforce real-world effectiveness against RSV disease and hospitalization in infants
September 27, 2024
Press Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPD
September 27, 2024
Press Release: Dupixent approved in China as the first-ever biologic medicine for patients with COPD